About Karius
Karius is a life sciences company focused on generating genomic insights for infectious diseases with a liquid biopsy for infectious diseases. The Karius Test helps clinicians make rapid treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer a major threat to human health. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing.
Open positions (9)
Associate Clinical Sales Manager (Lexington)
Manager, Digital Marketing
Senior Software Engineer
Clinical Sales Manager (Western Region)
Clinical Sales Manager (Eastern Region)
Clinical Sales Manager (Central Region)
Associate Clinical Sales Manager (Fort Lauderdale)
Senior Manager, Market Intelligence & Development
Associate Clinical Sales Manager (Dallas-Fort Worth)
Company details
Funding
Total raised
$315M
Last stage
Series C
Investors
Founders
Mickey Kertesz
Co-founded Karius in 2014, building on pathogen detection technology developed at Stanford. Previously CEO and co-founder of Moleculo (acquired by Illumina). PhD in computational biology from Weizmann Institute of Science; postdoctoral work in bioengineering at Stanford.
LinkedInTim Blauwkamp
Co-founder and CSO of Karius. Previously Staff Scientist at Illumina and Head of Molecular Biology at Moleculo. Background in chemistry and biochemistry from Grand Valley State University.
Stephen Quake
Co-founder of Karius. Renowned Stanford professor in bioengineering whose lab developed the foundational microbial cell-free DNA technology underlying the Karius Test.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.
